
Corporate
TG Therapeutics Eyes $900M Revenue as BRIUMVI Takes Market Share from Roche, Novartis
6d ago
You're signed outSign in or to get full access.
Browse quarterly earnings call transcripts for TG THERAPEUTICS.
Nov 3, 2025
Aug 4, 2025
May 5, 2025
Mar 3, 2025
Nov 4, 2024